• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; VALVE REPAIR Back to Search Results
Catalog Number CDS0502
Device Problem Incomplete Coaptation (2507)
Patient Problems Stroke/CVA (1770); Hemolysis (1886); Tachycardia (2095); Tissue Damage (2104)
Event Date 05/25/2020
Event Type  Injury  
Manufacturer Narrative
The clip was explanted and will not be returning.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report the single leaflet device attachment (slda).It was reported that this was a mitraclip procedure performed to treat grade 4 degenerative mitral regurgitation (mr).The first clip was implanted in a3/p3; however, the clip detached from the anterior leaflet and remained attached to the posterior leaflet (slda) and anterior leaflet injury occurred.A second clip was implanted medial to the first clip, stabilizing the slda clip.Mr was reduced to 3+.Post clip implantation, the patient experienced several complications (embolic disease, hemolytic anemia, hypokalemia resulting in torsades de pointes).On (b)(6) 2020, mitral valve replacement surgery was performed.On (b)(6) 2020, the patient was in stable condition.The symptoms of embolic disease resolved and the patient was in physical therapy for walking.No additional information was provided.
 
Event Description
Subsequent to the initially filed report, the following information was received: postoperative day one, of the mitraclip procedure; the embolic disease occurred, and bilirubin increased, (symptom of cerebral infarction).Postoperative day two, hemolytic anemia was diagnosed.Postoperative day three, torsades de pointes (tdp) occurred.Hemolytic anemia and tdp recovered through a surgical procedure.The patient got well and was discharged.In the physician¿s opinion, the mitraclip did not cause or contribute to the embolic disease.However, there is a possibility the mitraclip caused or contributed to the hemolytic anemia the mitraclip did not cause or contribute to the tdp/hypokalemia, however the cause of hypokalemia is unknown.No additional information provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot-specific quality issue.It should be noted that the reported patient effects of tissue damage, cerebrovascular accident, hemolysis and tachycardia, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.This event was further reviewed by an abbott vascular medical affairs director who stated in this case of grade 4 degenerative mitral regurgitation (mr), the first clip was implanted in a3/p3 but detached from the anterior leaflet and anterior leaflet injury occurred.A second clip was implanted medial to the first clip, stabilizing the slda clip.Mr was reduced to 3+.Post clip implantation, the patient experienced several complications (embolic disease, hemolytic anemia, hypokalemia resulting in torsades de pointes).3 days post-procedure, mitral valve replacement surgery was performed.The patient recovered and was discharged.In the physician¿s opinion, the mitraclip did not cause or contribute to the embolic disease.The investigation was unable to determine a conclusive cause for the reported single leaflet device attachment/slda and patient effects of cerebrovascular accident, hemolysis and tachycardia.The tissue damage appears to be related to the slda.There is no evidence that the embolic disease was related to the device but maybe related to the procedure.There is no indication of a product issue with respect to manufacture, design, or labeling.Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10165901
MDR Text Key195551187
Report Number2024168-2020-05131
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/06/2020
Device Catalogue NumberCDS0502
Device Lot Number91007U126
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/25/2020
Initial Date FDA Received06/17/2020
Supplement Dates Manufacturer Received08/06/2020
Supplement Dates FDA Received08/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
STEERABLE GUIDE CATHETER; STEERABLE GUIDE CATHETER
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age90 YR
Patient Weight45
-
-